Implications of IL-13Rα2 in atopic skin inflammation

Allergol Int. 2020 Jul;69(3):412-416. doi: 10.1016/j.alit.2020.01.005. Epub 2020 Feb 6.

Abstract

Atopic dermatitis (AD) is a common eczematous skin disorder characterized by skin inflammation, barrier disruption, chronic pruritus and marked scratching. Th2 cytokines, especially IL-13, play a pathogenic role in AD. IL-13 signals via a heterodimeric receptor composed of IL-4Rα and IL-13 Rα1. A second receptor, IL-13 Rα2, binds to IL-13 with high affinity, but it works as a decoy receptor. IL-13 Rα2 is overexpressed in the lesional skin of AD. Notably, mechanical scratching, as well as IL-13 itself, also upregulates IL-13 Rα2 expression. The scratch-induced IL-13 Rα2 upregulation may attenuate the IL-13-mediated epidermal barrier dysfunction and dermal fibrosis. Recent studies stress an importance of another IL-13 Rα2 ligand, chitinase 3-like 1 or YKL-40 in Th2 differentiation. However, the implications of increased IL-13 Rα2 levels remain elusive in AD. In this review, we summarize the recent topics on IL-13 Rα2 in atopic skin inflammation.

Keywords: Atopic dermatitis; IL-13; IL-13Rα2; Scratch; YKL-40.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Cytokines / metabolism
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / etiology*
  • Dermatitis, Atopic / metabolism
  • Dermatitis, Atopic / therapy
  • Disease Susceptibility*
  • Gene Expression Regulation
  • Humans
  • Interleukin-13 / metabolism
  • Interleukin-13 Receptor alpha1 Subunit / genetics*
  • Interleukin-13 Receptor alpha1 Subunit / metabolism
  • Signal Transduction
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism

Substances

  • Biomarkers
  • Cytokines
  • IL13RA1 protein, human
  • Interleukin-13
  • Interleukin-13 Receptor alpha1 Subunit